| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| SELENITE, SODIUM, SELENOMETHIONINE | TOX-REPRO - reproductive success | hatchability compared to controls | decreased @ 25 ppm (selenite), 10 ppm (selenomethionine) | 5-11 pairs/group | Juvenile | NR | Toxicity Factor Datasets |
| SELENOMETHIONINE | TOX-REPRO - reproductive success | hatchability compared to controls | decreased @ 8, 16 ppm | 5-11 pairs/group | Juvenile | NR | Toxicity Factor Datasets |
| SELENITE, SODIUM, SELENOMETHIONINE | TOX-REPRO - development | number of embryos showing malformations or embryotoxicity compared to controls | increased @ 10,25 ppm (as selenite), 10 ppm (as selenomethionine) | 5-11 pairs/group | Embryo | NR | Toxicity Factor Datasets |
| SELENOMETHIONINE | TOX-REPRO - development | incidence of malformed embyros compared to controls | increased @ 8, 16 ppm | 5-11 pairs/group | Embryo | NR | Toxicity Factor Datasets |
| SELENITE, SODIUM, SELENOMETHIONINE | TOX-REPRO - development | plasma uric acid concentration in hatchlings versus controls | increased @ 25 ppm | 5-11 pairs/group | Juvenile | NR | Toxicity Factor Datasets |
| SELENITE, SODIUM, SELENOMETHIONINE | TOX-REPRO - development | plasma glutathione peroxidase activity in hatchlings compared to controls | increased @ 5, 10, 25 ppm (as selenite), 10 ppm (as selenomethionine) | 5-11 pairs/group | Juvenile | NR | Toxicity Factor Datasets |
